Your search returned 2 results

{0} results
{0} result

Blog Post

FDA Announces Policy for Unique Nonproprietary Names for Biologics and Biosimilars

In a Federal Register notice, FDA announced its draft guidance, “Nonproprietary Naming of Biological Products,” in which the agency articulates the need “for biological products licensed...

No results found for the matching keyword.

Loading data